Some patient groups that are part of the National Coalition on Health Care are not participating in that coalition's campaign against high drug prices, and at least one group left the coalition following the announcement of the effort. Those decisions to not join the campaign illustrate the difficulty in getting patient groups to unite against high drug prices, in part because drug makers often fund patient groups, yet patients are crucial to publicly pressuring drug companies to lower their prices,...